home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

ADAMs Answer To Heart Failure

  January, 13 2002 7:03
your information resource in human molecular genetics
In cases of increased blood pressure, the heart has to pump extra hard to circulate blood around the body. Because the heart is a muscle, over a period of time this extra exertion causes the muscle to grow larger - a phenomenon known as cardiac hypertrophy. Paradoxically, although the heart, namely the left ventricle, is larger, it is less effective and heart disease ensues. Thus, curing cardiac hypertrophy is a medical goal.

Scientists at Osaka University Faculty of Medicine in Japan have discovered a set of molecular events that may underlie cardiac hypertrophy and prove to be a target for drug intervention (Nature Medicine, Vol. 8, No. 1, p. 35, 01 Jan 02).

Shigeki Higashiyama and colleagues discovered that under increased pressure, a member of the ADAMs family of proteins, ADAM12, cleaves another molecule called HB-EGF that liberates EGF which is then able to go on and stimulate the growth of the heart muscle. Agents that block the action of ADAM12, such as KB-R7785, may therefore be useful in hypertrophy.

In an accompanying News & Views article (p. 20), James Liao of Brigham & Women's Hospital, Massachusetts points out the caveats of the findings. For example, he points out that other molecular pathways may compensate for the one put out of action by an ADAM12 inhibitor, and hypertrophy may occur even with this type of treatment.

Author contact:

Dr. James K. Liao
Cardiovascular Division, Department of Medicine
Brigham & Women's Hospital and Harvard Medical School
Cambridge, Massachusetts, USA
Tel: +1 617 768 8424
Fax: +1 617 768 8425
Email: jliao@rics.bwh.harvard.edu

Dr. Shigeki Higashiyama
Department of Biochemistry
School of Allied Health Science
Osaka University Faculty of Medicine
Osaka, Japan
Tel: +81 6 6879 3421
Fax: +81 6 6879 3429
E-mail: shigeki@sahs.med.osaka-u.ac.jp

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.